LabGenius & Sanofi partnership yields positive results from AI antibody discovery platform

Today, LabGenius, a pioneer in the use of AI and machine learning for antibody discovery, releases new data from its antibody discovery platform following a multi-year collaboration with Sanofi.

Related Keywords

Paris ,France General ,France , ,From Labgeniussep ,Big Pharma ,Domain Antibodies ,Antibody ,Antibody Discovery ,Machine Learning ,Technology ,